期刊文献+

5-脂氧化酶转基因小鼠模型的制备 被引量:2

Construction of a 5-Lipoxygenase Transgenic Mice
下载PDF
导出
摘要 目的建立5-脂氧化酶(5-LO)转基因小鼠进行动脉粥样硬化的发病分子机制的研究。方法通过显微注射的方法,将5-脂氧化酶基因片段(6.8 kb)导入BDF1受精卵雄原核并移植到同期受孕的假孕母鼠输卵管中,对产出仔鼠的鼠尾组织DNA进行PCR、Southern blot检测,对9、20、24号转基因小鼠分别提取腹腔细胞、骨髓细胞及脾、肾组织总RNA和蛋白,并采用RT-PCR、Western blot方法进行转录水平检测和蛋白表达检测。结果共产生25只子代小鼠,经PCR和Southern检测获得7只阳性小鼠,经RT-PCR和Western blot检测结果表明,9、20、24号转基因小鼠腹腔细胞、骨髓细胞、脾、肾5-LO和5-脂氧化酶激活蛋白(FLAP)在RNA和蛋白水平表达均高于正常BDF1对照小鼠,且统计学分析腹腔细胞、骨髓细胞表达均具有显著差异(P<0.05)。结论成功建立5-LO转基因小鼠模型。 Objective To construct a 5-lipoxygenase(5-LO) transgenic mouse model of atherosclerosis.Methods Purified 5-LO fragment was injected into male pronucli and the firtilized eggs were transplanted into pseudopregnant mice.PCR and Southern blot were used to detect the genotype of DNA separated from the newborn mouse tail tissues.RT-PCR and Western blot analysis were used to detect the gene transcription and expression.Results PCR and Southern blot results showed that 7 of 25 mice were transgenic mice.Expression of 5-LO and FLAP was found in the bone marrow,spleen,kidney,and peritoneal cells.Results of RT-PCR and Western blot showed that No.9,20,24 transgenic mice expressed a higher level of 5-LO and FLAP than those in the wild type C57BL/6 mice.The expression levels in bone marrow and peritoneal cells were significantly different(P〈0.05).Conclusion A 5-LO transgenic mouse line has been established in this study and may be used for future study on the function of 5-LO gene.
出处 《中国实验动物学报》 CAS CSCD 2010年第1期60-64,共5页 Acta Laboratorium Animalis Scientia Sinica
基金 辽宁省高校科研项目计划项目(2008S239) 辽宁省科技厅攻关项目(2008408002-2) 国家科技重大专项-药物安全评价技术平台建设项目(编号:2008ZX09305-004)
关键词 5-脂氧化酶 动脉粥样硬化 转基因 5-lipoxygenase Atherosclerosis Transgenic mice
  • 引文网络
  • 相关文献

参考文献8

  • 1Merched AJ, Ko K, Gotlinger KH, et al. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediatorsJ[ J]. The FASEB J. 2008, 22 (10) :3595 - 3606.
  • 2Cipollone F, Mezzetti A, Fazia ML, et al. Association between 5- lipoxygenase expression and plaque instability in humans[ J]. Arterioscler Thromb Vasc Biol. 2005, 25 : 1665 - 1670.
  • 3Lotzer K, Spanbroek R, Hildner M, et al. Differential leukotriene receptor expression and calcium responses in endothelial ceils and macrophages indicate 5-1ipoxygenase- dependent circuits of inflammation and atherogenesis [ J ]. Arterioscler. Thromb Vasc Biol. 2003, 23 (8) : e32 - e36.
  • 4徐也鲁.动脉粥样硬化——一种慢性炎症过程[J].中国动脉硬化杂志,2001,9(2):93-95. 被引量:187
  • 5Lotzer K, Funk CD, Habenicht AJ . The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis[ J]. Biochim Biophys Acta, 2005, 1736( 1 ) :30 - 37.
  • 6Aiello RJ, Bourassa PA, Lindsey S, et al. Leukotriene B4 receptor antagonism reduces monocytie foam cell in mice [ J ]. Arterioscler Thromb Vasc Biol. 2002, 22:443 -449.
  • 7Zhou YJ, Wang JH, Li L, et al. Expanding expression of the 5- lipoxygenase/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability [ J ]. Biochem Biophys Res Comm, 2007, 363:30 - 36.
  • 8Spanbroek R, Grabner R, Lotzer K, et al. Expanding expression of the 5- lipoxygenase pathway within the arterial wall during human atherogenesis[ J]. Proc Natl Acad Sci U S A, 2003, 100 (3) :1238 - 1243.

二级参考文献1

  • 1Yu H,Biochemistry,2000年,33卷,8期,601页

共引文献186

同被引文献43

  • 1梅卫义,杜志民,胡承恒,罗初凡,李怡,陈国伟.妊娠相关血浆蛋白A水平与不稳定心绞痛患者冠状动脉狭窄病变形态的关系[J].中山大学学报(医学科学版),2005,26(4):456-458. 被引量:15
  • 2Hanson GK, Robertson AK, Soderberg-Naucler C. Inflamma- tion and atherosclerosis[J]. Annu Rev Pathol, 2006, 1:297- 329.
  • 3Wang Q. Molecular genetics of coronary artery disease[J]. Curr Opin Cardiol, 2005, 20(3): 182-188.
  • 4Spanbroek R, Grabner R, Lotzer K, et al. Expanding expression of the 5-1ipoxygenase pathway within the arterial wall dur- ing human atherogenesis[J]. Proc Natl Acad Sci USA, 2003, 100(3): 1238-1243.
  • 5Merched AJ, Ko K, Gotlinger KH, et al. Atherosclerosis: evidence for impairment of resolution of vascular inflamma- tion governed by specific lipid mediators[J]. FASEB J, 2008, 22(10):3595-3606.
  • 6Hoshiko S, Radmark O, Samuelsson B. Characterization of the human 5-1ipoxygenase gene promoter[J]. Proc Natl Acad Sci USA, 1990, 87(23):9073-9077.
  • 7Dwyer JH, Hooman A, Dwyer KM, et al. Arachidonate 5- lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis [J]. N Engl J Med, 2004, 350(1):29-37.
  • 8Bennett CF, Chiang MY, Monia BP, et al. Regulation of 5- lipoxygenase and 5-1ipoxygenase activating protein expres- sion in HL-60 cells[J]. Biochem.J, 1993,289:33-39.
  • 9Dixon RAF, Diehl RE, Opas E, et al. Requirement of a 5- lipoxygenase-activating protein for leukotriene synthesis[J]. Nature, 1990, 343(6225):282-284.
  • 10Vickers PJ, O eill GP, Mancini JA, et al. Cross-species comparison of 5-1ipoxygenase activating protein[J]. Mol. Pharmacol, 1992, 42:1014-1029.

引证文献2

;
使用帮助 返回顶部